We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for Drug development support services.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

Drug development support services - List of Manufacturers, Suppliers, Companies and Products

Drug development support services Product List

1～3 item / All 3 items

Displayed results
Ohsugi Biopharma Consulting Co., Ltd. Business Introduction

Ohsugi Biopharma Consulting Co., Ltd. Business Introduction

For consulting in pharmaceutical development, please feel free to contact us!

Ohsugi BioPharma Consulting Co., Ltd. is a company primarily engaged in pharmaceutical development support services. We provide consulting services in five areas: drug discovery research, CMC development, regenerative medicine, clinical development, and business development, with consultants who are well-versed in the fundamental research of biopharmaceuticals and the CMC development/quality assurance of both low molecular weight drugs and biopharmaceuticals/regenerative medicine products, supporting the global development of pharmaceuticals. In addition to this business, we also conduct seminar services and paper writing services. [Business Activities] ■ Pharmaceutical Development Support Services ■ Seminar Services ■ Paper Writing Services *For more details, please refer to our catalog or feel free to contact us.

  • Other Consulting Services
  • Product Development

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Antibody drug development support service "CAMouse"

Antibody drug development support service "CAMouse"

A fully human antibody mouse that ensures the normal development of B cells and directly expresses fully human IgG!

The "CAMouse" is a fully human antibody mouse that directly expresses fully human IgG while ensuring the normal development of B cells in mice. Human immunoglobulin heavy chain and K/λ light chain genes have been introduced, while simultaneously inactivating the endogenous heavy and light chain genes in the mouse. Seventy human immunoglobulin V regions, including 32 VH, 22 VK, and 16 Vλ, have been incorporated, providing a rich diversity of rearrangement. [Technological Advantages] ■ Establishment of efficient transgenic technology for ultra-large genes (>500kb) ■ Development of technology to spatially and temporally control B cell development in the host animal, allowing for the production of fully human IgG all at once. *For more details, please download the PDF or feel free to contact us.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Related Categories of Drug development support services

COPYRIGHT © 2001-2025 IPROS CORPORATION ALL RIGHTS RESERVED.